2.0mg Buprenorphine/0.5mg Naloxone
RB-US-08-0003
Approved small_molecule completed
Quick answer
2.0mg Buprenorphine/0.5mg Naloxone for Hepatic Failure is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Hepatic Failure
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed